The Veteran is seeking compensation under 38 U.S.C. § 1151 for CIDP, a condition he developed as a result of taking VA-prescribed Leflunomide. The Board has determined that further medical examination and opinion are needed to determine if the additional disability was caused by VA's carelessness or negligence.
The deciding factor: The claim is remanded due to the need for an independent medical opinion to assess whether the Veteran's CIDP was caused by VA's carelessness, negligence, lack of proper skill, error in judgment, or similar instance of fault on VA's part.
- Claimed conditions
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- September 15, 2022
- Citation
- 22052684
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 22052684.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied the Veteran's claim for service connection for bilateral upper and lower peripheral neuropathy, to include CIDP and carpal tunnel syndrome, as there was no probative evidence linking these conditions to his military service.
- Denied
The Board denied the Veteran's claim for service connection for CIDP due to herbicide exposure, finding that there was no evidence of a relationship between his CIDP and his military service.
- Denied
The Board denied the Veteran's claim for service connection for GBS and CIDP, finding that there was no evidence of their onset during or related to his active service.
- Granted
The Veteran developed chronic inflammatory demyelinating polyneuropathy (CIDP) as an additional disability due to VA-prescribed leflunomide. The Board found that the proximate cause of CIDP was not reasonably foreseeable and granted compensation under 38 U.S.C. § 1151.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.